Neoadjuvant Chemotherapy before Nephroureterectomy in High-Risk Upper Tract Urothelial Cancer: A Systematic Review and Meta-Analysis.

Cancers (Basel) · 2022 · PMC9562891 · PMID 36230764

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Three studies reported on five-year PFS with a positive trend in favor of neoadjuvant therapy, but without reaching significance (OR 1.78; 95% CI 0.92; 3.44) ( Figure 14 ).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.